156 related articles for article (PubMed ID: 34307918)
1. Risk of radiation-induced second malignant neoplasms from photon and proton radiotherapy in paediatric abdominal neuroblastoma.
Taylor S; Lim P; Ahmad R; Alhadi A; Harris W; Rompokos V; D'Souza D; Gaze M; Gains J; Veiga C
Phys Imaging Radiat Oncol; 2021 Jul; 19():45-52. PubMed ID: 34307918
[TBL] [Abstract][Full Text] [Related]
2. Pencil Beam Scanning Proton Therapy Case Selection for Paediatric Abdominal Neuroblastoma: Effects of Tumour Location and Bowel Gas.
Lim PS; Rompokos V; Bizzocchi N; Gillies C; Gosling A; Royle G; Chang YC; Gaze MN; Gains JE
Clin Oncol (R Coll Radiol); 2021 Mar; 33(3):e132-e142. PubMed ID: 32962907
[TBL] [Abstract][Full Text] [Related]
3. Out-of-field doses in pediatric craniospinal irradiations with 3D-CRT, VMAT, and scanning proton radiotherapy: A phantom study.
Majer M; Ambrožová I; Davídková M; De Saint-Hubert M; Kasabašić M; Knežević Ž; Kopeć R; Krzempek D; Krzempek K; Miljanić S; Mojżeszek N; Veršić I; Stolarczyk L; Harrison RM; Olko P
Med Phys; 2022 Apr; 49(4):2672-2683. PubMed ID: 35090187
[TBL] [Abstract][Full Text] [Related]
4. Proton pencil beam scanning reduces secondary cancer risk in breast cancer patients with internal mammary chain involvement compared to photon radiotherapy.
Cartechini G; Fracchiolla F; Menegotti L; Scifoni E; La Tessa C; Schwarz M; Farace P; Tommasino F
Radiat Oncol; 2020 Oct; 15(1):228. PubMed ID: 33008412
[TBL] [Abstract][Full Text] [Related]
5. Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas.
Fuji H; Schneider U; Ishida Y; Konno M; Yamashita H; Kase Y; Murayama S; Onoe T; Ogawa H; Harada H; Asakura H; Nishimura T
Radiat Oncol; 2013 Nov; 8():255. PubMed ID: 24180282
[TBL] [Abstract][Full Text] [Related]
6. Lifetime attributable risk of radiation induced second primary cancer from scattering and scanning proton therapy - A model for out-of-field organs of paediatric patients with cranial cancer.
Dell'Oro M; Short M; Wilson P; Peukert D; Hua CH; Merchant TE; Bezak E
Radiother Oncol; 2022 Jul; 172():65-75. PubMed ID: 35504365
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
[TBL] [Abstract][Full Text] [Related]
8. Pencil Beam Scanning Proton Therapy for Paediatric Neuroblastoma with Motion Mitigation Strategy for Moving Target Volumes.
Lim PS; Pica A; Hrbacek J; Bachtiary B; Walser M; Lomax AJ; Weber DC
Clin Oncol (R Coll Radiol); 2020 Jul; 32(7):467-476. PubMed ID: 32081577
[TBL] [Abstract][Full Text] [Related]
9. Proton pencil beam scanning for mediastinal lymphoma: treatment planning and robustness assessment.
Zeng C; Plastaras JP; James P; Tochner ZA; Hill-Kayser CE; Hahn SM; Both S
Acta Oncol; 2016; 55(9-10):1132-1138. PubMed ID: 27332881
[TBL] [Abstract][Full Text] [Related]
10. The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric patients with brain tumors.
Moteabbed M; Yock TI; Paganetti H
Phys Med Biol; 2014 Jun; 59(12):2883-99. PubMed ID: 24828559
[TBL] [Abstract][Full Text] [Related]
11. Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer.
Gort EM; Beukema JC; Matysiak W; Sijtsema NM; Aluwini S; Langendijk JA; Both S; Brouwer CL
Radiother Oncol; 2021 Jan; 154():194-200. PubMed ID: 32956707
[TBL] [Abstract][Full Text] [Related]
12. Estimated Risk of Radiation-Induced Cancer after Thymoma Treatments with Proton- or X-ray Beams.
Lideståhl A; Johansson G; Siegbahn A; Lind PA
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680302
[TBL] [Abstract][Full Text] [Related]
13. Whole-ventricular irradiation for intracranial germ cell tumors: Dosimetric comparison of pencil beam scanned protons, intensity-modulated radiotherapy and volumetric-modulated arc therapy.
Correia D; Terribilini D; Zepter S; Pica A; Bizzocchi N; Volken W; Stieb S; Ahlhelm F; Herrmann E; Fix MK; Manser P; Aebersold DM; Weber DC
Clin Transl Radiat Oncol; 2019 Feb; 15():53-61. PubMed ID: 30734001
[TBL] [Abstract][Full Text] [Related]
14. Cancer Control, Toxicity, and Secondary Malignancy Risks of Proton Radiation Therapy for Stage I-IIB Testicular Seminoma.
Maxwell R; Chang Y; Paul C; Vaughn DJ; Christodouleas JP
Adv Radiat Oncol; 2023; 8(5):101259. PubMed ID: 37408671
[TBL] [Abstract][Full Text] [Related]
15. Risk for second bladder and rectal malignancies from cervical cancer irradiation.
Mazonakis M; Lyraraki E; Tolia M; Damilakis J
J Appl Clin Med Phys; 2021 Jul; 22(7):103-109. PubMed ID: 34021692
[TBL] [Abstract][Full Text] [Related]
16. Deep learning prediction of proton and photon dose distributions for paediatric abdominal tumours.
Guerreiro F; Seravalli E; Janssens GO; Maduro JH; Knopf AC; Langendijk JA; Raaymakers BW; Kontaxis C
Radiother Oncol; 2021 Mar; 156():36-42. PubMed ID: 33264639
[TBL] [Abstract][Full Text] [Related]
17. Second malignant neoplasm risk after craniospinal irradiation in X-ray-based techniques compared to proton therapy.
Sakthivel V; Ganesh KM; McKenzie C; Boopathy R; Selvaraj J
Australas Phys Eng Sci Med; 2019 Mar; 42(1):201-209. PubMed ID: 30725439
[TBL] [Abstract][Full Text] [Related]
18. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
[TBL] [Abstract][Full Text] [Related]
19. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
[TBL] [Abstract][Full Text] [Related]
20. Clinical Implementation of Preoperative Short-Course Pencil Beam Scanning Proton Therapy for Patients With Rectal Cancer.
Jeans EB; Jethwa KR; Harmsen WS; Neben-Wittich M; Ashman JB; Merrell KW; Giffey B; Ito S; Kazemba B; Beltran C; Haddock MG; Hallemeier CL
Adv Radiat Oncol; 2020; 5(5):865-870. PubMed ID: 33083648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
